Log In
BCIQ
Print this Print this
 

ONO-4059

  Manage Alerts
Collapse Summary General Information
Company Ono Pharmaceutical Co. Ltd.
DescriptionBruton's tyrosine kinase (Btk) inhibitor
Molecular Target Bruton's tyrosine kinase (Btk)
Mechanism of ActionBruton's tyrosine kinase (Btk) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationB cell lymphoma
Indication DetailsTreat B cell lymphoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/19/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today